BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24711169)

  • 1. HNF4A immunohistochemistry facilitates distinction between primary and metastatic breast and gastric carcinoma.
    van der Post RS; Bult P; Vogelaar IP; Ligtenberg MJ; Hoogerbrugge N; van Krieken JH
    Virchows Arch; 2014 Jun; 464(6):673-9. PubMed ID: 24711169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of the combined use of HNF4A and GATA3 in distinction between primary and metastatic breast and gastric carcinomas.
    Saad DZ; Sidhom KF; Gadallah MF; Samir NA; Shakweer MM
    APMIS; 2021 Sep; 129(9):548-555. PubMed ID: 34120367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte nuclear factor 4A expression discriminates gastric involvement by metastatic breast carcinomas from primary gastric adenocarcinomas.
    Koyama T; Sekine S; Taniguchi H; Tsuda H; Ikegami M; Hano H; Kushima R
    Hum Pathol; 2011 Nov; 42(11):1777-84. PubMed ID: 21733563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HNF4A expression as a potential diagnostic tool to discriminate primary gastric cancer from breast cancer metastasis in a Brazilian cohort.
    Jucá PCFC; Corrêa S; Vignal GM; Accioly MTS; Lustosa SAS; Abdelhay E; Matos D
    Diagn Pathol; 2017 Jun; 12(1):43. PubMed ID: 28583188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract.
    O'Connell FP; Wang HH; Odze RD
    Arch Pathol Lab Med; 2005 Mar; 129(3):338-47. PubMed ID: 15737028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of oestrogen receptor and loss of E-cadherin are diagnostic for gastric metastasis of breast carcinoma.
    van Velthuysen ML; Taal BG; van der Hoeven JJ; Peterse JL
    Histopathology; 2005 Feb; 46(2):153-7. PubMed ID: 15693887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of estrogen receptor and progesterone receptor immunohistochemistry in the distinction of metastatic breast carcinoma from other tumors in the liver.
    Nash JW; Morrison C; Frankel WL
    Arch Pathol Lab Med; 2003 Dec; 127(12):1591-5. PubMed ID: 14632573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung.
    Hattori Y; Yoshida A; Yoshida M; Takahashi M; Tsuta K
    Pathol Int; 2015 Jun; 65(6):286-92. PubMed ID: 25727644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
    Zhao M; Sun L; Lai JZ; Shi H; Mei K; He X; Jin X; Lai J; Cao D
    Pathol Res Pract; 2018 Oct; 214(10):1707-1712. PubMed ID: 30196987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of bcl-2 by breast cancer: a possible diagnostic application.
    Alsabeh R; Wilson CS; Ahn CW; Vasef MA; Battifora H
    Mod Pathol; 1996 Apr; 9(4):439-44. PubMed ID: 8729986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53.
    Bassarova AV; Nesland JM; Sedloev T; Lilleby W; Hristova SL; Trifonov DY; Torlakovic E
    Int J Surg Pathol; 2005 Jul; 13(3):239-46. PubMed ID: 16086078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity of estrogen/progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin.
    Wallace ML; Smoller BR
    Am J Dermatopathol; 1996 Jun; 18(3):241-7. PubMed ID: 8806958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric metastasis from breast cancer: a pitfall in gastric biopsy specimens.
    Shimizu M; Matsumoto T; Hirokawa M; Shimozuma K; Manabe T
    Pathol Int; 1998 Mar; 48(3):240-1. PubMed ID: 9589495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions.
    Lew M; Pang JC; Jing X; Fields KL; Roh MH
    Cancer Cytopathol; 2015 Oct; 123(10):576-81. PubMed ID: 26465236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.
    Cimino-Mathews A; Subhawong AP; Illei PB; Sharma R; Halushka MK; Vang R; Fetting JH; Park BH; Argani P
    Hum Pathol; 2013 Jul; 44(7):1341-9. PubMed ID: 23375642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of monoclonal antibody HIK1083 specific for gastric O-glycan in differentiating cutaneous metastasis of gastric cancer from primary sweat gland carcinoma.
    Iijima M; Nakayama J; Nishizawa T; Ishida A; Ishii K; Ota H; Katsuyama T; Saida T
    Am J Dermatopathol; 2007 Oct; 29(5):452-6. PubMed ID: 17890913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating breast carcinoma with signet ring features from gastrointestinal signet ring carcinoma: assessment of immunohistochemical markers.
    Hui Y; Wang Y; Nam G; Fanion J; Sturtevant A; Lombardo KA; Resnick MB
    Hum Pathol; 2018 Jul; 77():11-19. PubMed ID: 29317235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of HNF4A and β-catenin expression to predict low-grade dysplasia in the colitis-neoplastic sequence.
    He Y; Chen L; Chen K; Sun Y
    Acta Biochim Biophys Sin (Shanghai); 2021 Jan; 53(1):94-101. PubMed ID: 33300557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.